☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC December Update

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Flecainide modified release 200mg capsules (Tambocor XL®) have been accepted for use in treating a variety of cardiac arrhythmias including AV nodal reciprocating tachycardia, Wolff-Parkinson-White Syndrome and atrial fibrillation in patients with disabling symptoms. It is also noted that the once-daily product has a lower acquisition cost than a twice-daily product at equivalent doses.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC December Update' by emailShare 'SMC December Update' on FacebookShare 'SMC December Update' on TwitterShare 'SMC December Update' on LinkedInShare 'SMC December Update' on reddit


No Comments to “SMC December Update”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.